Skip to main content
logo
Brenntag SE (ETR:BNR)
Germany flag Germany · Delayed Price · Currency is EUR
53.50
-1.04 (-1.91%)
Aug 1, 2025, 5:35 PM CET

Revance Therapeutics Revenue

Brenntag SE had revenue of 4.07B EUR in the quarter ending March 31, 2025, with 1.73% growth. This brings the company's revenue in the last twelve months to 16.31B, up 0.10% year-over-year. In the year 2024, Brenntag SE had annual revenue of 16.24B, down -3.44%.

Revenue (ttm)
16.31B
Revenue Growth
+0.10%
P/S Ratio
0.47
Revenue / Employee
900.92K
Employees
18,122
Market Cap
7.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.24B-577.70M-3.44%
Dec 31, 202316.82B-2.61B-13.45%
Dec 31, 202219.43B5.05B35.09%
Dec 31, 202114.38B2.59B21.94%
Dec 31, 202011.79B-1.03B-8.01%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BASF SE64.77B
Heidelberg Materials AG21.25B
Covestro AG14.15B
Symrise AG4.99B
Evonik Industries AG15.14B
Wacker Chemie AG5.71B
K+S Aktiengesellschaft3.63B
LANXESS Aktiengesellschaft6.36B
Revenue Rankings

Brenntag SE News

More News